DA

Dianne Angus

Cyclopharm Limited | Non-Executive Director
Ms Angus was appointed to the Board on 10 August 2021. She is a member of the Audit and Risk Committee, Remuneration Committee and Board Nomination Committee. Ms Angus has executive managerial and company director experience in the biotechnology, biopharmaceutical, medical device, agritech and healthcare industries. She has long been involved in path to market asset development and commercialisation in these industries, notably including the clinical validation of therapeutics to create asset valuation uplift. Ms Angus has wide expertise in corporate strategy and innovative product development together with governance and compliance in listed capital markets.

Companies and Roles

Company
Title
Tenure
Since
CYC
Cyclopharm Limited
  • Non-Executive Director
2yrs, 11mthAug 2021
AGN
Argenica Therapeutics Limited
  • Non-Executive Director
7mthDec 2023
NEU
Neuren Pharmaceuticals Limited
  • Non-Executive Director
6yrsJul 2018

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CYC
Cyclopharm Limited
28/06/2422,323N/AN/AN/A
NEU
Neuren Pharmaceuticals Limited
22/03/2430,000N/AN/AN/A
AGN
Argenica Therapeutics Limited
01/12/230N/AN/AN/A
21/04/23323,375N/A500,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CYC
Cyclopharm Limited
28/06/24
Issued
12,323$1.420$17,500Participation in share purchase plan
21/04/23
Issued
50,000$0.017$850As advised by the company
21/04/23
Issued
30,375$0.017$516Rights issue
CYC
Cyclopharm Limited
29/11/22
Buy
1,254$1.300$1,630On-market trade
CYC
Cyclopharm Limited
24/11/22
Buy
8,746$1.300$11,369On-market trade